Cargando…
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Nitric oxide (NO) is a short-lived gas molecule which has been studied for its role as a signaling molecule in the vasculature and later, in a broader view, as a cellular messenger in many other biological processes such as immunity and inflammation, cell survival, apoptosis, and aging. Fractional e...
Autores principales: | Maniscalco, Mauro, Fuschillo, Salvatore, Mormile, Ilaria, Detoraki, Aikaterini, Sarnelli, Giovanni, de Paulis, Amato, Spadaro, Giuseppe, Cantone, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649630/ https://www.ncbi.nlm.nih.gov/pubmed/37947596 http://dx.doi.org/10.3390/cells12212518 |
Ejemplares similares
-
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us?
por: Maniscalco, Mauro, et al.
Publicado: (2023) -
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
por: Mormile, Mauro, et al.
Publicado: (2023) -
Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis
por: Ambrosino, Pasquale, et al.
Publicado: (2021) -
Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
por: Ambrosino, Pasquale, et al.
Publicado: (2022) -
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
por: Detoraki, Aikaterini, et al.
Publicado: (2021)